Torrent Pharmaceuticals Limited has informed the Exchange regarding 'Intimation pursuant to Regulation 8(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 '.
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Torrent Pharmaceuticals has informed the exchanges about the revision of its Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI), as required under Regulation 8(2) of SEBI's Prohibition of Insider Trading Regulations, 2015. The Board of Directors approved the revised code at a meeting held on 20th May 2025. The updated code has been uploaded to the company's official website. The company secretary, Chintan M. Trivedi, signed and submitted the intimation to both BSE and NSE. This is a standard regulatory compliance communication.
This is a routine compliance filing with no material impact on the company's financials or stock price. It reflects Torrent Pharma's adherence to SEBI's insider trading and fair disclosure norms, reinforcing its governance practices.